Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07432529Phase 3Not Yet Recruiting

Design and Rationale of the COLT Study

Role: lead

NCT03489603Completed

Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation Myocardial Infarction in Patients With Chest Pain in Emergency Departments in Italy-An Observational Study

Role: collaborator

NCT02809638Completed

A New Technique to Diagnose Acute and Chronic Deep Vein Thrombosis

Role: lead

NCT02114983Completed

General Practitioner-performed Compression Ultrasound for Deep Vein Thrombosis

Role: lead

All 4 trials loaded